Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
BMJ Open. 2012 Dec 12;2(6). doi: 10.1136/bmjopen-2012-002104. Print 2012.
Diastolic dysfunction (DD) is often incriminated in the symptomatology of patients with hypertrophic cardiomyopathy (HCM), but with limited supporting data. This study sought to assess the relationship between baseline diastolic function and exercise capacity in patients with HCM.
Retrospective study.
Tertiary referral centre from Cleveland, Ohio, USA.
695 consecutive patients with a diagnosis of HCM who underwent exercise stress echocardiography between 1996 and 2011.
Diastolic function was reassessed from the resting echocardiograms by two blinded board-certified cardiologists. Maximal metabolic equivalents (MET) were extracted from the records. Multivariate regression analysis was performed to determine independent predictors of METs achieved.
Of 695 patients, 130 were excluded because of inability to assess diastolic function. There was no significant difference in maximal METs achieved between those excluded and included in the analysis (p=0.80). There were 495 remaining patients with a mean age (SD) of 50 (15) years, and 32% women among whom 102 (21%) had normal diastolic function, 243 (49%) stage 1 DD; 131 (26%) stage 2 DD and 19 (4%) stage 3 DD. Patients with advanced DD had lower maximal METs achieved compared with those with normal diastolic function (OR 3.18(1.96 to 5.14) for stage 1 versus normal, and 3.21(1.89 to 5.43) for stage ≥2 versus normal, p<0.0001 for both). After adjustment for demographics, comorbidities, echocardiographic parameters and haemodynamics, baseline DD was not an independent predictor of maximal METs achieved.
Although baseline DD is common in patients with HCM, it does not predict maximal METs achieved beyond traditional risk factors.
舒张功能障碍(DD)常被认为与肥厚型心肌病(HCM)患者的症状有关,但缺乏支持性数据。本研究旨在评估 HCM 患者基线舒张功能与运动能力之间的关系。
回顾性研究。
美国俄亥俄州克利夫兰市的三级转诊中心。
1996 年至 2011 年间接受运动负荷超声心动图检查的 695 例连续 HCM 患者。
由两位经过盲法认证的心脏病专家从静息超声心动图中重新评估舒张功能。从记录中提取最大代谢当量(MET)。进行多变量回归分析以确定达到的 METs 的独立预测因素。
在 695 例患者中,有 130 例因无法评估舒张功能而被排除。在排除和纳入分析的患者中,达到的最大 METs 之间没有显著差异(p=0.80)。在剩余的 495 例患者中,平均年龄(标准差)为 50(15)岁,女性占 32%,其中 102 例(21%)舒张功能正常,243 例(49%)为 1 期 DD;131 例(26%)为 2 期 DD,19 例(4%)为 3 期 DD。与舒张功能正常的患者相比,晚期 DD 患者的最大 METs 较低(1 期与正常相比,OR 为 3.18(1.96 至 5.14),≥2 期与正常相比,OR 为 3.21(1.89 至 5.43),均<0.0001)。在调整了人口统计学、合并症、超声心动图参数和血液动力学后,基线 DD 不是达到最大 METs 的独立预测因素。
尽管 HCM 患者的基线 DD 很常见,但它并不能预测传统危险因素以外的最大 METs。